# A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

> **NCT07712393** · PHASE1 · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 24 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** GSK5784283

## Key facts

- **NCT ID:** NCT07712393
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-17
- **Primary completion:** 2027-04-13
- **Final completion:** 2027-04-26
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07712393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07712393, "A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07712393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*